Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study

Abstract

Symptomatic VTE is a frequent complication of chemotherapy. The prechemotherapy platelet count is a unique risk factor and can help identify high-risk patients for future trials of thromboprophylaxis.